Basel, Switzerland

Christian Bisang

This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Polyphor Ag, Polyphor Ltd., Unversität Zürich. Active years: 2014-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Bisang. Retrieved from https://idiyas.com/inventor/christian-bisang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 50.0


 

Average Co-Inventor Count = 7.1

ph-index = 5

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Christian Bisang

Introduction

Christian Bisang is a distinguished inventor based in Basel, Switzerland, known for his significant contributions to the field of medicinal chemistry. With a total of eight patents to his name, he has been instrumental in developing novel compounds that are essential for treating various medical conditions, including type 2 diabetes and cardiovascular disorders.

Latest Patents

Among his latest patents is the development of backbone-cyclized peptidomimetics that exhibit GLP-1 receptor modulating activity. These innovative molecules, characterized by the general formula cyclo[-P-P-P-P-P-P-P-P-T-T-], consist of α-amino acid residues configured to enhance modulation of the GLP-1 receptor. This capability is particularly beneficial for creating therapeutics aimed at treating, preventing, or delaying diseases linked to GLP-1 receptor functionality, such as type 2 diabetes.

Additionally, Bisang has patented template-fixed β-hairpin peptidomimetics, demonstrating the potential to act as agonists or antagonists for GPCR receptors including CXCR3, urotensin, and CCR10. These compounds can be utilized in treating various conditions such as cardiovascular disorders and cancer. The innovative synthesis processes for these peptidomimetics are based on a mixed solid- and solution-phase strategy, showcasing his advanced approach to drug design.

Career Highlights

Christian Bisang’s career features notable positions in companies like Polyphor AG and Polyphor Ltd., where he has significantly contributed to pharmaceutical research and development. His innovative mindset and expertise have positioned him as a key player in his field, leading to patent awards that highlight his solutions to pressing medical needs.

Collaborations

Throughout his career, Bisang has collaborated with several esteemed colleagues, including Daniel Obrecht and Alexander Lederer. These partnerships have fostered a collaborative environment that has amplified his research efforts and has advanced the development of innovative medicinal compounds.

Conclusion

Christian Bisang exemplifies excellence in innovation within the pharmaceutical industry. His impressive portfolio of patents attests to his ability to create impactful solutions for significant medical challenges. As he continues to work on novel drug therapies, his contributions will undoubtedly play a crucial role in advancing healthcare and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…